Arianna Damiani

Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.

María Infantino, Arianna Damiani, Francesca Li Gobbi et al. · PubMed · 2020 · 132 citations

Viral Diagnostics, Emerging Infectious Diseases, Covid-19 Pandemic +8

Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study

Maurizio Benucci, Francesca Li Gobbi, Francesca Bandinelli et al. · Immunologic Research · 2016 · 59 citations

Rheumatoid Disorder, Rheumatology, Spondyloarthritis +8

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study

Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti et al. · International Journal of Infectious Diseases · 2022 · 43 citations · Full text

Closing the serological gap in the diagnostic testing for COVID‐19: The value of anti‐SARS‐CoV‐2 IgA antibodies

María Infantino, Mariangela Manfredi, Valentina Grossi et al. · Journal of Medical Virology · 2020 · 42 citations · Full text

Particular Immunoglobulin, Coronavirus Disease 2019, Molecular Diagnostic Techniques +15

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

Antonella Fioravanti, Sara Tenti, Arianna Damiani et al. · PubMed · 2019 · 39 citations